A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Hong Yuan Holding Group (“We”, “the Company”, “Hong Yuan”, Us” or “Our”) was incorporated on September 29, 2001, in the State of Nevada under the name of Biocorp North America Inc. On March 18, 2005, we filed an amendment to our certificate of incorporation to change our name to Cereplast, The Company is a development-stage enterprise devoting substantial efforts to establishing a new business, financial planning, raising capital, and researching products that may become part of the Company’s product portfolio. The Company has not realized significant sales since inception. A development stage company is defined as one in which all efforts are devoted substantially to establishing a new business and, even if planned principal operations have commenced, revenues are insignificant.
| Metric | TTM | FY2024 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|
| Revenue | 858K | 246K | - | 20M | 6.3M |
| Net Income | 49K | -99K | -30M | -14M | -7.5M |
| EPS | $0.00 | $-0.00 | $-58.00 | $-44.00 | $-32.00 |
| Free Cash Flow | 0 | -90K | -187K | -33M | -8.9M |
| ROIC | 13.1% | -34.2% | -94.9% | -82.4% | -128.5% |
| Gross Margin | 56.3% | 37.8% | - | 10.0% | 17.3% |
| Debt/Equity | 0.00 | -0.40 | -0.19 | 0.76 | 0.31 |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | 69K | -96K | -19M | -12M | -6.9M |
| Operating Margin | 8.0% | -39.2% | - | -61.3% | -108.6% |
| ROE | 0.0% | - | - | -144.4% | -108.7% |
| Shares Outstanding | 75M | 75M | 7M | 7M | 0M |
| Metric | 2010 | 2011 | |||
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 6.3M | 20M | N/A | 246K | 858K |
| Gross Margin | 17.3% | 10.0% | N/A | 37.8% | 56.3% |
| R&D | 466K | 1.0M | 471K | N/A | N/A |
| SG&A | 7.5M | 13M | 19M | 152K | 318K |
| EBIT | -6.9M | -12M | -19M | -96K | 69K |
| Op. Margin | -108.6% | -61.3% | N/A | -39.2% | 8.0% |
| Net Income | -7.5M | -14M | -30M | -99K | 49K |
| Net Margin | -118.0% | -69.1% | N/A | -40.3% | 5.7% |
| Non-Recurring | 586K | 647K | 61K | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -128.5% | -82.4% | -94.9% | -34.2% | 13.1% |
| ROE | -108.7% | -144.4% | N/A | N/A | 0.0% |
| ROA | -57.7% | -38.6% | -115.0% | -81.7% | 11.3% |
| Cash Flow | |||||
| Op. Cash Flow | -8.6M | -25M | -5K | -90K | -118K |
| Free Cash Flow | -8.9M | -33M | -187K | -90K | 0 |
| Owner Earnings | -9.4M | -26M | -945K | -91K | -120K |
| CapEx | 263K | 7.9M | 182K | 0 | 0 |
| Maint. CapEx | 803K | 944K | 874K | 1K | 2K |
| Growth CapEx | 0 | 7.0M | 0 | N/A | 0 |
| D&A | 803K | 944K | 874K | 1K | 2K |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | N/A | 0.0% |
| Stock-Based Comp | N/A | N/A | 66K | N/A | N/A |
| Debt Repayment | 59K | 145K | 366K | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | -2.7M | -500K | 1.5M | 0 | -25K |
| Cash & Equiv. | 2.4M | 3.9M | 183K | 46K | 25K |
| Long-Term Debt | 2.1M | 7.3M | 923K | N/A | N/A |
| Debt/Equity | 0.31 | 0.76 | -0.19 | -0.40 | 0.00 |
| Interest Coverage | -459.2 | -7.8 | -20.4 | -5350.1 | -5350.1 |
| Equity | 6.9M | 9.7M | -10M | -231K | -112K |
| Total Assets | 13M | 36M | 16M | 223K | 430K |
| Total Liabilities | 6.1M | 27M | 26M | 391K | 476K |
| Intangibles | 170K | 183K | 245K | N/A | N/A |
| Retained Earnings | -43M | -57M | -87M | -98M | -98M |
| Working Capital | 5.2M | 18M | -7.6M | -243K | -71K |
| Current Assets | 9.1M | 24M | 7.5M | 129K | 405K |
| Current Liabilities | 4.0M | 6.5M | 15M | 372K | 476K |
| Per Share Data | |||||
| EPS | -32.00 | -44.00 | -58.00 | -0.00 | 0.00 |
| Owner EPS | -40.30 | -3.86 | -0.14 | -0.00 | -0.00 |
| Book Value | 29.44 | 1.46 | -1.51 | -0.00 | -0.00 |
| Cash Flow/Share | -36.87 | -3.72 | -0.00 | -0.00 | 0.00 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 0.2M | 6.7M | 6.7M | 74.6M | 74.6M |
| Valuation | |||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | 123.5 |
| Price/Book | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | 8.0 | 9.9 |
| FCF Yield | N/A | N/A | N/A | -2.4% | N/A |
| Market Cap | 0 | 0 | 0 | 3.7M | 8.5M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.03 | 0.11 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.05 | 0.11 |
HONG YUAN HOLDING GROUP passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 21.7%.
HONG YUAN HOLDING GROUP (HGYN) has a 5-year average return on invested capital (ROIC) of -85.0%. This is below average and may indicate limited pricing power.
HONG YUAN HOLDING GROUP (HGYN) has a market capitalization of $9M. It is classified as a small-cap stock.
HONG YUAN HOLDING GROUP (HGYN) does not currently pay a regular dividend.
HONG YUAN HOLDING GROUP (HGYN) operates in the Plastic Materials, Synth Resins & Nonvulcan Elastomers industry, within the Materials sector.
HONG YUAN HOLDING GROUP (HGYN) reported annual revenue of $246 thousand in its most recent fiscal year, based on SEC EDGAR filings.
HONG YUAN HOLDING GROUP (HGYN) has a net profit margin of -40.3%. The company is currently unprofitable.
HONG YUAN HOLDING GROUP (HGYN) generated $-90 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
HONG YUAN HOLDING GROUP (HGYN) has a 5-year average gross margin of 21.7%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 4 years of financial data for HONG YUAN HOLDING GROUP (HGYN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
HONG YUAN HOLDING GROUP (HGYN) has a book value per share of $-0.00, based on its most recent annual SEC filing.
No recent press releases.